BM-18 PROLONGED RESPONSE WITH BEVACIZUMAB + NAVELBINE AS THIRD LINE OF TREATMENT OF BREAST CANCER LEPTOMENINGEAL METASTASES: A CASE REPORT

Approximately 5% of breast cancer (BC) will develop leptomeningeal metastases (LM) during the course of the disease. The median overall survival remains limited to several months despite aggressive treatment. We report the case of a patient with a prolonged response to bevacizumab (BEV) and vinorelb...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Le Rhun, Emilie, Taillibert, Sophie, Zairi, Fahed, Boulanger, Thomas, Farre, Isabelle, Deligny, Nathalie, Bachelot, Thomas, Bonneterre, Jacques
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Oxford University Press 2014
विषय:
Abstracts
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4217918/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou240.18
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन